Liontrust Investment Partners LLP Sells 36,584 Shares of Intuitive Surgical, Inc. $ISRG

Liontrust Investment Partners LLP lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.5% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 234,532 shares of the medical equipment provider’s stock after selling 36,584 shares during the period. Intuitive Surgical makes up 1.8% of Liontrust Investment Partners LLP’s investment portfolio, making the stock its 14th biggest position. Liontrust Investment Partners LLP’s holdings in Intuitive Surgical were worth $127,447,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Brighton Jones LLC increased its holdings in Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after purchasing an additional 731 shares in the last quarter. Kovitz Investment Group Partners LLC grew its holdings in shares of Intuitive Surgical by 0.9% during the first quarter. Kovitz Investment Group Partners LLC now owns 7,847 shares of the medical equipment provider’s stock worth $3,887,000 after purchasing an additional 72 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Intuitive Surgical by 1.5% in the first quarter. Dimensional Fund Advisors LP now owns 574,954 shares of the medical equipment provider’s stock valued at $284,746,000 after buying an additional 8,521 shares during the period. Element Capital Management LLC bought a new position in Intuitive Surgical in the 1st quarter valued at approximately $2,653,000. Finally, EverSource Wealth Advisors LLC boosted its position in Intuitive Surgical by 11.1% during the 1st quarter. EverSource Wealth Advisors LLC now owns 1,344 shares of the medical equipment provider’s stock worth $666,000 after buying an additional 134 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, insider Gary S. Guthart sold 28,800 shares of the stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $547.56, for a total transaction of $15,769,728.00. Following the transaction, the insider directly owned 27,027 shares in the company, valued at approximately $14,798,904.12. This represents a 51.59% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Brian Edward Miller sold 3,500 shares of Intuitive Surgical stock in a transaction on Monday, November 10th. The shares were sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the completion of the sale, the executive vice president owned 5,758 shares of the company’s stock, valued at $3,310,850. This represents a 37.81% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 109,043 shares of company stock valued at $60,816,225. 0.70% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities analysts have issued reports on the stock. Hsbc Global Res upgraded shares of Intuitive Surgical to a “strong-buy” rating in a research report on Thursday, October 23rd. Daiwa Capital Markets increased their price objective on Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a report on Friday, October 24th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, October 31st. Wells Fargo & Company upped their price target on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a research report on Friday. Finally, UBS Group set a $600.00 price objective on Intuitive Surgical and gave the stock a “neutral” rating in a research report on Thursday, October 23rd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $608.79.

Intuitive Surgical Trading Down 0.9%

Shares of Intuitive Surgical stock opened at $542.32 on Friday. The business has a 50-day moving average price of $529.62 and a two-hundred day moving average price of $505.69. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The company has a market cap of $194.41 billion, a P/E ratio of 71.74, a PEG ratio of 4.98 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. During the same period in the previous year, the business earned $1.84 EPS. The firm’s revenue was up 22.9% compared to the same quarter last year. Equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.